- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Perrigo Company PLC(PRGO)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PRGO
11/13/2026: PRGO (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Perrigo Company PLC is a major player in the consumer self-care market, specializing in store-brand over-the-counter medications and wellness products. The company's strengths lie in its deep-rooted retail partnerships and extensive manufacturing scale, which allow it to provide high-quality, cost-effective health solutions. Its primary growth story revolves around consolidating its position in international markets and leveraging the increasing consumer shift toward affordable health alternatives. However, Perrigo faces risks related to intense competition from national health brands and the complexities of integrating past acquisitions. It may suit dividend-seeking value investors, while shareholders should monitor its progress in streamlining margins and reducing debt.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth is largely dependent on successful M&A and brand expansion rather than rapid organic innovation. |
| Momentum investor | Mixed fit | Momentum may be inconsistent; investors should monitor for signs of a sustained breakout in organic growth. |
| Value investor | Strong fit | Perrigo often trades at valuation multiples that may appeal to investors looking for stability in the consumer health sector. |
| Dividend investor | Strong fit | Consistent dividend payouts make it an attractive option for income-focused portfolios. |
| Low-risk investor | Mixed fit | Regulatory and integration risks add a layer of complexity that may not suit the most conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock can be sensitive to quarterly earnings reports and changes in market sentiment regarding consumer spending. |
| Valuation risk | Medium | While often priced reasonably, valuation is tied to the company's ability to maintain earnings stability. |
| Competition risk (Generic & Brand competition) | High | Perrigo faces constant margin pressure from competitors and national brand manufacturers. |
| Business quality | Medium | The franchise is solid but has faced challenges in executing a coherent long-term strategy across regions. |
| Dividend income | Medium | Dividends are reliable but not typically characterized by high-growth characteristics. |
| Execution risk | Medium / high | Successful integration of large acquisitions remains the primary determinant of long-term value creation. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.25B USD | Price to earnings Ratio - | 1Y Target Price 18 |
Price to earnings Ratio - | 1Y Target Price 18 | ||
Volume (30-day avg) 2.4M shares | Beta 0.69 | 52 Weeks Range 8.81 - 17.02 | Updated Date 11/14/2026 |
52 Weeks Range 8.81 - 17.02 | Updated Date 11/14/2026 | ||
Dividends yield (FY) 7.17% | Basic EPS (TTM) -12.47 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Drug Manufacturers - Specialty & Generic
- BUY participation
- 66.7%
- Active BUY / eligible
- 8 / 12
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -43.65% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Consumer Self-Care Americas | Store-brand OTC medications for retail pharmacies and grocery chains. | This is the core engine of the company, providing steady revenue through private-label sales. |
| Consumer Self-Care International | Branded and private-label products across the European and international markets. | This segment provides international diversification but faces varying regulatory and competitive landscapes. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-04 | When Before Market | Estimate 0.56 | Actual 0.6 |
Profitability
Profit Margin -43.27% | Operating Margin (TTM) 5.53% |
Management Effectiveness
Return on Assets (TTM) 1.61% | Return on Equity (TTM) -50.25% |
Valuation
Trailing PE - | Forward PE 7.03 | Enterprise Value 5.10B | Price to Sales(TTM) 0.55 |
Enterprise Value 5.10B | Price to Sales(TTM) 0.55 | ||
Enterprise Value to Revenue 1.25 | Enterprise Value to EBITDA 10.21 | Shares Outstanding 138.80M | Shares Floating 138.10M |
Shares Outstanding 138.80M | Shares Floating 138.10M | ||
Percent Insiders 0.39 | Percent Institutions 119.96 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

